- Home
- ADPT vs TASK Comparison
ADPT vs TASK Comparison
Compare ADPT & TASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- TASK
- Stock Information
- Founded
- ADPT 2009
- TASK 2008
- Country
- ADPT United States
- TASK United States
- Employees
- ADPT N/A
- TASK N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- TASK Retail: Computer Software & Peripheral Equipment
- Sector
- ADPT Health Care
- TASK Technology
- Exchange
- ADPT Nasdaq
- TASK Nasdaq
- Market Cap
- ADPT 1.8B
- TASK 1.5B
- IPO Year
- ADPT 2019
- TASK 2021
- Fundamental
- Price
- ADPT $12.92
- TASK $17.26
- Analyst Decision
- ADPT Strong Buy
- TASK Buy
- Analyst Count
- ADPT 8
- TASK 6
- Target Price
- ADPT $12.38
- TASK $17.67
- AVG Volume (30 Days)
- ADPT 2.1M
- TASK 196.2K
- Earning Date
- ADPT 08-05-2025
- TASK 08-07-2025
- Dividend Yield
- ADPT N/A
- TASK N/A
- EPS Growth
- ADPT N/A
- TASK 21.25
- EPS
- ADPT N/A
- TASK 0.67
- Revenue
- ADPT $205,216,000.00
- TASK $1,101,465,000.00
- Revenue This Year
- ADPT $24.39
- TASK $14.37
- Revenue Next Year
- ADPT $20.44
- TASK $8.00
- P/E Ratio
- ADPT N/A
- TASK $25.62
- Revenue Growth
- ADPT 21.60
- TASK 19.04
- 52 Week Low
- ADPT $3.98
- TASK $10.57
- 52 Week High
- ADPT $13.37
- TASK $19.60
- Technical
- Relative Strength Index (RSI)
- ADPT 69.79
- TASK 62.50
- Support Level
- ADPT $10.66
- TASK $16.96
- Resistance Level
- ADPT $13.37
- TASK $17.22
- Average True Range (ATR)
- ADPT 0.81
- TASK 0.10
- MACD
- ADPT 0.23
- TASK -0.01
- Stochastic Oscillator
- ADPT 86.82
- TASK 73.48
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world's most innovative companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.